Glypicans in growth control and cancer

Glycobiology

Volumn 11, Issue 3, 2001, Pages

  Filmus, Jorge ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Glypicans; Heparan sulfate proteoglycans; Overgrowth syndromes

Indexed keywords

FIBROBLAST GROWTH FACTOR; GLYPICAN; PHOSPHATIDYLINOSITOL; PROTEOHEPARAN SULFATE; SOMATOMEDIN;

ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL MEMBRANE; CONTROLLED STUDY; DEVELOPMENT; DOWN REGULATION; DROSOPHILA; EMBRYO; GENE MUTATION; GENETICS; GROWTH REGULATION; HYPOTHESIS; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MESOTHELIOMA; MOLECULE; MORPHOGENESIS; MOUSE; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SIMPSON GOLABI BEHMEL SYNDROME; TERATOLOGY; TISSUE SPECIFICITY;

ANIMALIA; MAMMALIA;

EID: 0035005707     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/11.3.19R     Document Type: Article

References (57)

1. Baeg, G.H., Lin, X., Khare, N., Baumgartner, S., and Perrimon, N. (2001) Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development, 126, 87-94.
2. Baeg, G.H. and Perrimon, N. (2000) Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr. Opin.Cell Biol., 12, 575-580.
3. Beasley, R.P., Hwang, L.Y., Lin, C.C., and Chien, C.S. (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet, 2, 1129-1132.
4. Binari, R.C., Staveley, B.E., Johnson, W.A., Godovarti, R., Sasisekharan, R., and Manoukian, A.S. (1997) Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development, 124, 2623-2632.
5. Bonneh-Barkay, D., Shlissel, M., Berman, B., Shaoul, E., Adnion, A., Vlodavsky, I., Carey, D.J., Asundi, V.K., Reich-Slotky, R., and Ron, D. (1997) Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors. J. Biol. Chem., 272, 12415-12421.
6. Cano-Gauci, D.F., Song, H., Yang, H., McKerlie, C., Choo, B., Shi, W., Pullano, R., Piscione, T.D., Grisaru, S., Soon, S., and others (1999) Glypican-3-deficient mice exhibit the overgrowth and renal abnormalities typical of the Simpson-Golabi-Behmel syndrome. J. Cell Biol., 146, 255-264.
7. Coggin, J.H. Jr. (1992) The implications of embryonic gene expression in neoplasia. CRC Crit. Rev. Onco./Hemat., 5, 37-55.
8. David, G., Lories, V., Decock, B., Marynen, P., Cassiman, J., and Van Den Berghe, H. (1990) Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J. Cell Biol., 111, 3165-3176.
9. Duenas Gonzales, A., Kaya, M., Shi, W., Song, H., Testa, J.R., Penn, L.Z., and Filmus, J. (1998) OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J. Cell. Biol., 141, 1407-1414.
10. Eggenschwiler, J., Ludwig, T., Fisher, P., Leighton, P.A., Tilghman, S.M., and Efstratiadis, A. (1997) Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes & Develop., 11, 3128-3142.
11. Filmus, J., Church, J., and Buick, R.N. (1988) Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol. Cell. Biol., 8, 4243-4249.
12. Filmus, J., Shi, W., Wong, Z.M., and Wong, M.J. (1995) Identification of a new membrane-bound heparan sulfate proteoglycan. Biochem. J., 311, 561-565.
13. Hsu, H.C., Cheng, W., and Lai, P.L. (1997) Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res., 57, 5179-5184.
14. Hughes-Benzie, R.M., Pilia, G., Xuan, J.Y., Hunter, A.G.W., Chen, E., Golabi, M., Hurst, J.A., Kobori, J., Marymee, K., Pagon, R.A., and others (1996) Simpson-Golabi-Behmel Syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am. J. Med. Genet., 66, 227-234.
15. Ivins, J.K., Litwack, E.D., Kumbasar, A., Stipp, C.S., and Lander, A.D. (1997) Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones. Dev. Biol., 184, 320-332.
16. Jackson, S.M., Nakato, H., Sugiura, M., Jannuzi, A., Oakes, R., Kaluza, V., Golden, C., and Selleck, S.B. (1997) dally, a Drosophila glypican, controls celular responses to the TGF-beta-related morphogen Dpp. Development, 124, 4113-4120.
17. Kleef, J., Ishiwata, T., Kumbasar, A., Friess, H., Buchler, M.W., Lander, A.D., and Korc, M. (1998) The cell surface heparan sulfate proteoglycan glypican-1 regulates growth factor in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J. Clin. Invest., 102, 1662-1673.
18. Kleeff, J., Wildi, S., Kumbasar, A., Friess, H., Lander, A.D., and Korc, M. (1999) Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas, 19, 281-288.
19. Lau, M.M., Stewart, C.E., Liu, Z., Bhatt, H., Rotwein, P., and Stewart, C.L. (1994) Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev., 8, 2953-2963.
20. Li, M., Choo, B., Wong, Z.-M., Filmus, J., and Buick, R.N. (1997) Expression of OCI-5/Glypican 3 during intestinal morphogenesis: Regulation by cell shape in intestinal epithelial cells. Exp. Cell Res., 235, 3-12.
21. Lin, H., Huber, R., Schlessinger, D., and Morin, P.J. (1999a) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res., 59, 807-810.
22. Lin, X. and Perrimon, N. (1999) Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signaling. Nature, 400, 281-284.
23. Lin, X., Buff, E.M., Perrimon, N., and Michelson, A.M. (1999b) Heparan sulfate proteoglycans are essential for FGF receptor siganlling during Drosophila embryonic development. Development, 126, 3715-3723.
24. Lindsay, S., Ireland, H., O'Brien, O., Clayton-Smith, J., Hurst, J.A., Mann, J., Cole, T., Sampson, J., Slaney, S., Schlessinger, D., and others (1997) Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J. Med. Genet., 34, 480-483.
25. Litwack, E.D., Ivins, J.K., Kumbasar, A., Paine-Saunders, S., Stipp, C.S., and Lander, A.D. (1998) Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn., 211, 72-87.
26. Litwack, E.D., Stipp, C.S., Kumbasar, A., and Lander, A.D. (1994) Neuronal expression of glypican, a cell surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system. J. Neurosci., 14, 3713-3724.
27. Ludwig, T., Eggenschwiler, J., Fisher, P., D'Ercole, A.J., Davenport, M.L., and Efstratiadis, A. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev. Biol., 177, 517-535.
28. Matsuura, H., and Hakomori, S-I. (1985) The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: Its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc. Natl. Acad. Sci. USA, 82, 6517-6521.
29. Murthy, S.S., Shen, T., De Rienzo, A., Lee, W.C., Ferriola, P.C., Jhanwar, S.C., Mossman, B.T., Filmus, J., and Testa, J.R. (2000) Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene, 19, 410-416.
30. Nakato, H., Futch, T.A., and Selleck, S.B. (1995) The division abnormally delayed (dally) gene: a putative integral membrane proteoglycan required for cell division patterning during postembryonic development of the nervous system in Drosophila. Development, 121, 3687-3702.
31. Neri, G., Gurrieri, F., Zanni, G., and Lin, A. (1998) Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am. J. Med. Genet., 79, 279-283.
32. Paine-Saunders, S., Viviano, B.L., and Saunders, S. (1999) GPC6. a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics, 57, 455-458.
33. Paine-Saunders, S., Viviano, B.L., Zupicich, J., Skarnes, W.C., and Saunders, S. (2000) Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev. Biol., 225, 179-187.
34. Pellegrini, M., Pilia, G., Pantano, S., Lucchini, F., Uda, M., Fumi, M., Cao, A., Schlessinger, D., and Forabosco, A. (1998) Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev. Dyn., 213, 431-439.
35. Pilia, G., Hughes-Benzie, R.M., MacKenzie, A., Baybayan, P., Chen, E.Y., Huber, R., Neri, G., Cao, A., Forabosco, A., and Schlessinger, D. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nature Genet., 12, 241-247.
36. Reichsman, F., Smith, L., and Cumberledge, S. (1996) Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J. Cell Biol., 135, 819-827.
37. Saunders, S., Paine-Saunders, S., and Lander, A.D. (1997) Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain. Dev. Biol., 190, 78-93.
38. Schlessinger, J. (2000) Crystal structure of a ternary FGF-FGFR-Heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell, 6, 743-750.
39. Schlessinger, J., Lax, I., and Lemmon, M. (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell, 83, 357-360.
40. Siebertz, B., Stocker, G., Drzeniek, Z., Handt, S., Just, U., and Haubeck, H.-D. (1999) Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells. Biochem J., 344, 937-943.
41. Song, H.H., Shi, W., and Filmus, J. (1997) OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2. J. Biol. Chem., 272, 7574-7577.
42. Stauber, D.J., Digabriele, A.D., and Hendrickson, W.A. (2000) Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. USA, 97, 49-54.
43. Steinfeld, R., Van Den Berghe, H., and David, G. (1996) Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J. Cell Biol., 133, 405-416.
44. Stipp, C.S., Litwac, E.D., and Lander, A.D. (1994) Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation. J. Cell Biol., 124, 149-160.
45. Tsuda, M., Kamimura, K., Nakato, H., Archer, M., Staatz, W., Fox, B., Humphrey, M., Olson, S., Futch, T., Kaluza, V., and others (1999) The cell-surface proteoglycan Dally regulates Wingless signaling in Drosophila. Nature, 400, 276-280.
46. Venkataraman, G., Raman, R., Sasisekharan, V., and Sasisekharan, R. (1999) Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Proc. Natl. Acad. Sci. USA, 96, 3658-3663. 1-1-1999.
47. Veugelers, M., De Cat, B., Ceulemans, H., Bruystens, A.M., Coomans, C., Durr, J., Vermeesch, J., Marynen, P., and David, G. (1999) Glypican-6, a new member of the glypican family of cell surface proteoglycans. J. Biol. Chem., 274, 26968-26977.
48. Veugelers, M., De Cat, B., Muyldermans, S.Y., Reekmans, G., Delande, N., Frints, S., Legius, E., Fryns, J.P., Scrander-Stumpel, C., Weidle, B., and others (2000) Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum. Mol. Genet., 9, 1321-1328.
49. Veugelers, M., Vermeesch, J., Reekmans, G., Steinfeld, R., Marynen, P., and David, G. (1997) Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics, 40, 24-30.
50. Veugelers, M., Vermeesch, J., Watanabe, K., Yamaguchi, Y., Marynen, P., and David, G. (1998) GPC4, the gene for human K-glypican, flanks GPC3 on Xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics, 53, 1-11.
51. Vollmer, C.M., Eilber, F.C., Butterfield, L.H., Ribas, A., Dissette, V.B., Koh, A., Montejo, L.D., Lee, M.C., Andrews, K.J., McBride, W.H., and others (1999) Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res., 59, 3064-3067.
52. Wang, Z.Q., Fung, M.R., Barlow, D.P., and Wagner, E.F. (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature, 372, 464-467.
53. Watanabe, K., Yamada, H., and Yamaguchi, Y. (1995) K-glypican: a novel GPI-linked heparan sulfate proteoglycan that is highly expressed in developing brain and kidney. J. Cell Biol., 130, 1207-1218.
54. Weksberg, R. and Squire, J.A. (1997) Molecular biology of Beckwith-Wiedemann syndrome. Med. Pediatric Oncol., 27, 462-469.
55. Weksberg, R., Squire, J.A., and Templeton, D.M. (1996) Glypicans: a growing trend. Nature Genet., 12, 225-227.
56. Weng, E.Y., Mortier, G.R., and Graham, J.M. (1995) Beckwith-Wiedemann syndrome. Clin. Pediat., 317-326.
57. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., and Ornitz, D.M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.